The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Differential cognitive and behavioral effects of carbamazepine and lamotrigine
Abstract
BACKGROUND: The relative cognitive and behavioral effects of lamotrigine compared with the older standard antiepileptic drugs (AED) are uncertain. OBJECTIVE: To directly compare the cognitive and behavioral effects of carbamazepine and lamotrigine. METHODS: The cognitive and behavioral effects of carbamazepine and lamotrigine were assessed in 25 healthy adults using a double-blind, randomized crossover design with two 10-week treatment periods. During each treatment condition, subjects received either lamotrigine (150 mg/day) or carbamazepine (mean 696 mg/day) adjusted to a dose to achieve midrange standard therapeutic blood levels (mean 7.6 microg/mL). Subjects were tested at the end of each AED treatment period and in three drug-free conditions (two pretreatment baselines and a final posttreatment period [1 month after last AED]). The neuropsychological test battery included 19 measures yielding 40 total variables. RESULTS: Direct comparison of the two AED revealed significantly better performance on 19 (48%) variables for lamotrigine but none for carbamazepine. Differences spanned both objective cognitive and subjective behavioral measures, including cognitive speed, memory, graphomotor coding, neurotoxic symptoms, mood factors, sedation, perception of cognitive performance, and other quality-of-life perceptions. Comparison of carbamazepine with the nondrug average revealed significantly better performance for nondrug average on 24 (62%) variables but none for carbamazepine. Comparison of lamotrigine with nondrug average revealed better performance on one (2.5%) variable for nondrug average and on one (2.5%) variable for lamotrigine. CONCLUSION: Lamotrigine produces significantly fewer untoward cognitive and behavioral effects than carbamazepine at the dosages used in this study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calabrese, J. R., Bowden, C. L., Sachs, G. S., Ascher, J. A., Monaghan, E., Rudd, G. D., & The Lamictal 602 Study Group (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0203 · Cited by 1,054
Development of the Quality of Life in Epilepsy Inventory
Devinsky, O., Vickrey, B. G., Cramer, J., Perrine, K., Hermann, B., Meador, K., & Hays, R. D. (1995) · Epilepsia · doi:10.1111/j.1528-1157.1995.tb00467.x · Cited by 634
Self-citation
Cited by
Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy
Chen, B., Choi, H., Hirsch, L. J., Katz, A., Legge, A., Buchsbaum, R., & Detyniecki, K. (2017) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2017.08.039 · Cited by 399
Optimizing health outcomes in active epilepsy
Gilliam, F. (2002) · Neurology · doi:10.1212/wnl.58.8_suppl_5.s9 · Cited by 334
Cognitive side effects of antiepileptic drugs
Ortinski, P., & Meador, K. J. (2004) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2003.11.008 · Cited by 316
Self-citationMotamedi, G., & Meador, K. (2003) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2003.07.004 · Cited by 302
Self-citationCognitive Effects of Antiepileptic Drugs
Park, S.-P., & Kwon, S.-H. (2008) · Journal of Clinical Neurology · doi:10.3988/jcn.2008.4.3.99 · Cited by 271
Metadata
- Authors
- Meador, K. J., Loring, D. W., Ray, P. G., Murro, A. M., King, D. W., Perrine, K. R., Vazquez, B. R., & Kiolbasa, T.
- Venue
- Neurology
- Published
- 2001-05-08
- Volume
- 56
- Issue
- 9
- Pages
- 1177-1182
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2044642402
- Cited by
- 166
- References
- 2
- FWCI
- 9.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Differential cognitive and behavioral effects of carbamazepine and lamotrigine. https://app.cochat.ai/papers/10.1212/wnl.56.9.1177
- The paper
- Meador, K. J., Loring, D. W., Ray, P. G., Murro, A. M., King, D. W., Perrine, K. R., Vazquez, B. R., & Kiolbasa, T. (2001). Differential cognitive and behavioral effects of carbamazepine and lamotrigine. Neurology. https://doi.org/10.1212/wnl.56.9.1177
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.